nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PPARG—colon cancer	0.193	0.561	CbGaD
Indomethacin—PTGS2—colon cancer	0.0816	0.237	CbGaD
Indomethacin—ABCB1—colon cancer	0.0693	0.202	CbGaD
Indomethacin—CES1—Capecitabine—colon cancer	0.0638	0.134	CbGbCtD
Indomethacin—ABCC11—Methotrexate—colon cancer	0.0503	0.106	CbGbCtD
Indomethacin—CES1—Irinotecan—colon cancer	0.0394	0.0829	CbGbCtD
Indomethacin—ABCC3—Fluorouracil—colon cancer	0.0251	0.0529	CbGbCtD
Indomethacin—UGT1A9—Irinotecan—colon cancer	0.0239	0.0503	CbGbCtD
Indomethacin—ABCC3—Vincristine—colon cancer	0.0229	0.0482	CbGbCtD
Indomethacin—SLC22A7—Fluorouracil—colon cancer	0.0197	0.0414	CbGbCtD
Indomethacin—UGT1A1—Irinotecan—colon cancer	0.0196	0.0412	CbGbCtD
Indomethacin—ABCC4—Fluorouracil—colon cancer	0.0192	0.0404	CbGbCtD
Indomethacin—ABCC1—Irinotecan—colon cancer	0.0161	0.0338	CbGbCtD
Indomethacin—ABCC1—Vincristine—colon cancer	0.0141	0.0296	CbGbCtD
Indomethacin—ABCC3—Methotrexate—colon cancer	0.0139	0.0292	CbGbCtD
Indomethacin—SLCO1B1—Irinotecan—colon cancer	0.0136	0.0285	CbGbCtD
Indomethacin—ABCC2—Irinotecan—colon cancer	0.0119	0.025	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—colon cancer	0.0114	0.0239	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—colon cancer	0.0108	0.0228	CbGbCtD
Indomethacin—ABCC4—Methotrexate—colon cancer	0.0106	0.0223	CbGbCtD
Indomethacin—ABCC2—Vincristine—colon cancer	0.0104	0.0219	CbGbCtD
Indomethacin—ABCC1—Methotrexate—colon cancer	0.00851	0.0179	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—colon cancer	0.0076	0.016	CbGbCtD
Indomethacin—ALB—Irinotecan—colon cancer	0.00742	0.0156	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—colon cancer	0.00717	0.0151	CbGbCtD
Indomethacin—ALB—Fluorouracil—colon cancer	0.00712	0.015	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—colon cancer	0.00662	0.0139	CbGbCtD
Indomethacin—CYP2C9—Capecitabine—colon cancer	0.00647	0.0136	CbGbCtD
Indomethacin—ABCC2—Methotrexate—colon cancer	0.0063	0.0133	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—colon cancer	0.00461	0.0097	CbGbCtD
Indomethacin—SLC10A1—bile—colon cancer	0.00421	0.0714	CbGeAlD
Indomethacin—ALB—Methotrexate—colon cancer	0.00393	0.00826	CbGbCtD
Indomethacin—ABCB1—Irinotecan—colon cancer	0.00388	0.00816	CbGbCtD
Indomethacin—CYP2C9—Fluorouracil—colon cancer	0.00384	0.00807	CbGbCtD
Indomethacin—ABCB1—Vincristine—colon cancer	0.00339	0.00714	CbGbCtD
Indomethacin—ABCC2—bile—colon cancer	0.00211	0.0359	CbGeAlD
Indomethacin—ABCB1—Methotrexate—colon cancer	0.00205	0.00432	CbGbCtD
Indomethacin—PTGR2—embryo—colon cancer	0.00143	0.0244	CbGeAlD
Indomethacin—ABCC11—embryo—colon cancer	0.00142	0.0241	CbGeAlD
Indomethacin—PPARA—blood vessel—colon cancer	0.00129	0.0219	CbGeAlD
Indomethacin—PPARG—Topotecan—Irinotecan—colon cancer	0.00126	0.613	CbGdCrCtD
Indomethacin—PTGR2—renal system—colon cancer	0.00109	0.0184	CbGeAlD
Indomethacin—CES1—gall bladder—colon cancer	0.000901	0.0153	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vincristine—colon cancer	0.000797	0.387	CbGdCrCtD
Indomethacin—PTGR2—vagina—colon cancer	0.000786	0.0134	CbGeAlD
Indomethacin—PPARA—embryo—colon cancer	0.00077	0.0131	CbGeAlD
Indomethacin—PPARG—endothelium—colon cancer	0.000769	0.0131	CbGeAlD
Indomethacin—ABCC3—gall bladder—colon cancer	0.000734	0.0125	CbGeAlD
Indomethacin—GLO1—epithelium—colon cancer	0.000723	0.0123	CbGeAlD
Indomethacin—Bezafibrate—PPARG—colon cancer	0.000712	0.376	CrCbGaD
Indomethacin—PPARG—blood vessel—colon cancer	0.00071	0.012	CbGeAlD
Indomethacin—GLO1—smooth muscle tissue—colon cancer	0.000697	0.0118	CbGeAlD
Indomethacin—PLA2G2A—epithelium—colon cancer	0.000672	0.0114	CbGeAlD
Indomethacin—GLO1—renal system—colon cancer	0.000671	0.0114	CbGeAlD
Indomethacin—PTGR2—liver—colon cancer	0.000663	0.0113	CbGeAlD
Indomethacin—ABCC11—liver—colon cancer	0.000657	0.0112	CbGeAlD
Indomethacin—UGT1A9—renal system—colon cancer	0.000651	0.0111	CbGeAlD
Indomethacin—PLA2G2A—smooth muscle tissue—colon cancer	0.000648	0.011	CbGeAlD
Indomethacin—CXCL8—smooth muscle tissue—colon cancer	0.000641	0.0109	CbGeAlD
Indomethacin—PPARA—epithelium—colon cancer	0.000628	0.0107	CbGeAlD
Indomethacin—ALB—gall bladder—colon cancer	0.000626	0.0106	CbGeAlD
Indomethacin—PLA2G2A—renal system—colon cancer	0.000624	0.0106	CbGeAlD
Indomethacin—ABCC6—renal system—colon cancer	0.000617	0.0105	CbGeAlD
Indomethacin—PPARA—smooth muscle tissue—colon cancer	0.000605	0.0103	CbGeAlD
Indomethacin—PPARA—renal system—colon cancer	0.000583	0.00989	CbGeAlD
Indomethacin—SLC10A1—renal system—colon cancer	0.00056	0.00951	CbGeAlD
Indomethacin—GLO1—lymphoid tissue—colon cancer	0.000557	0.00946	CbGeAlD
Indomethacin—GLO1—digestive system—colon cancer	0.00055	0.00934	CbGeAlD
Indomethacin—Bromfenac—PTGS2—colon cancer	0.000544	0.287	CrCbGaD
Indomethacin—UGT1A9—digestive system—colon cancer	0.000534	0.00907	CbGeAlD
Indomethacin—UGT2B7—renal system—colon cancer	0.000525	0.00891	CbGeAlD
Indomethacin—PLA2G2A—lymphoid tissue—colon cancer	0.000518	0.00879	CbGeAlD
Indomethacin—SLC22A11—renal system—colon cancer	0.000512	0.00869	CbGeAlD
Indomethacin—PLA2G2A—digestive system—colon cancer	0.000512	0.00869	CbGeAlD
Indomethacin—PTGR2—lymph node—colon cancer	0.000509	0.00864	CbGeAlD
Indomethacin—GLO1—bone marrow—colon cancer	0.000507	0.00861	CbGeAlD
Indomethacin—AKR1C3—smooth muscle tissue—colon cancer	0.000503	0.00854	CbGeAlD
Indomethacin—SLC22A7—renal system—colon cancer	0.000499	0.00848	CbGeAlD
Indomethacin—GLO1—vagina—colon cancer	0.000486	0.00825	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—colon cancer	0.000484	0.00821	CbGeAlD
Indomethacin—PPARA—digestive system—colon cancer	0.000478	0.00811	CbGeAlD
Indomethacin—CXCL8—bone marrow—colon cancer	0.000467	0.00793	CbGeAlD
Indomethacin—SLC10A1—digestive system—colon cancer	0.000459	0.0078	CbGeAlD
Indomethacin—CXCL8—vagina—colon cancer	0.000447	0.00759	CbGeAlD
Indomethacin—UGT1A1—renal system—colon cancer	0.000446	0.00758	CbGeAlD
Indomethacin—UGT2B7—digestive system—colon cancer	0.000431	0.00731	CbGeAlD
Indomethacin—PPARG—embryo—colon cancer	0.000423	0.00719	CbGeAlD
Indomethacin—SLC22A11—digestive system—colon cancer	0.00042	0.00713	CbGeAlD
Indomethacin—PTGS1—endothelium—colon cancer	0.000411	0.00699	CbGeAlD
Indomethacin—GLO1—liver—colon cancer	0.00041	0.00696	CbGeAlD
Indomethacin—SLC22A7—digestive system—colon cancer	0.00041	0.00696	CbGeAlD
Indomethacin—UGT1A9—liver—colon cancer	0.000398	0.00676	CbGeAlD
Indomethacin—PTGS2—endothelium—colon cancer	0.000393	0.00668	CbGeAlD
Indomethacin—PLA2G2A—liver—colon cancer	0.000381	0.00647	CbGeAlD
Indomethacin—PTGS1—blood vessel—colon cancer	0.000379	0.00644	CbGeAlD
Indomethacin—CXCL8—liver—colon cancer	0.000377	0.00641	CbGeAlD
Indomethacin—ABCC6—liver—colon cancer	0.000377	0.00641	CbGeAlD
Indomethacin—SLCO1B1—renal system—colon cancer	0.000371	0.00631	CbGeAlD
Indomethacin—UGT1A1—digestive system—colon cancer	0.000366	0.00622	CbGeAlD
Indomethacin—AKR1C3—bone marrow—colon cancer	0.000366	0.00621	CbGeAlD
Indomethacin—Tolmetin—PTGS2—colon cancer	0.000365	0.193	CrCbGaD
Indomethacin—PTGS2—blood vessel—colon cancer	0.000363	0.00616	CbGeAlD
Indomethacin—CES1—lymphoid tissue—colon cancer	0.000359	0.0061	CbGeAlD
Indomethacin—PPARA—liver—colon cancer	0.000356	0.00605	CbGeAlD
Indomethacin—CES1—digestive system—colon cancer	0.000355	0.00602	CbGeAlD
Indomethacin—ABCC3—renal system—colon cancer	0.000352	0.00598	CbGeAlD
Indomethacin—AKR1C3—vagina—colon cancer	0.000351	0.00595	CbGeAlD
Indomethacin—PPARG—epithelium—colon cancer	0.000345	0.00587	CbGeAlD
Indomethacin—SLC10A1—liver—colon cancer	0.000342	0.00581	CbGeAlD
Indomethacin—PTGS2—gall bladder—colon cancer	0.000341	0.00579	CbGeAlD
Indomethacin—PPARG—smooth muscle tissue—colon cancer	0.000333	0.00565	CbGeAlD
Indomethacin—UGT2B7—liver—colon cancer	0.000321	0.00545	CbGeAlD
Indomethacin—PPARG—renal system—colon cancer	0.00032	0.00544	CbGeAlD
Indomethacin—GLO1—lymph node—colon cancer	0.000314	0.00534	CbGeAlD
Indomethacin—SLC22A11—liver—colon cancer	0.000313	0.00531	CbGeAlD
Indomethacin—SLC22A7—liver—colon cancer	0.000305	0.00518	CbGeAlD
Indomethacin—SLCO1B1—digestive system—colon cancer	0.000305	0.00517	CbGeAlD
Indomethacin—SLCO1A2—renal system—colon cancer	0.000302	0.00513	CbGeAlD
Indomethacin—AKR1C3—liver—colon cancer	0.000296	0.00502	CbGeAlD
Indomethacin—PLA2G2A—lymph node—colon cancer	0.000292	0.00496	CbGeAlD
Indomethacin—ABCC4—renal system—colon cancer	0.000291	0.00494	CbGeAlD
Indomethacin—CXCL8—lymph node—colon cancer	0.000289	0.00491	CbGeAlD
Indomethacin—ABCC3—digestive system—colon cancer	0.000289	0.00491	CbGeAlD
Indomethacin—SLC22A8—renal system—colon cancer	0.000289	0.0049	CbGeAlD
Indomethacin—ABCC2—renal system—colon cancer	0.000282	0.00478	CbGeAlD
Indomethacin—Naproxen—PTGS2—colon cancer	0.000275	0.145	CrCbGaD
Indomethacin—PPARA—lymph node—colon cancer	0.000273	0.00463	CbGeAlD
Indomethacin—UGT1A1—liver—colon cancer	0.000273	0.00463	CbGeAlD
Indomethacin—PPARG—lymphoid tissue—colon cancer	0.000266	0.00452	CbGeAlD
Indomethacin—CES1—liver—colon cancer	0.000264	0.00449	CbGeAlD
Indomethacin—PPARG—digestive system—colon cancer	0.000263	0.00446	CbGeAlD
Indomethacin—SLCO1A2—digestive system—colon cancer	0.000248	0.00421	CbGeAlD
Indomethacin—PPARG—bone marrow—colon cancer	0.000242	0.00411	CbGeAlD
Indomethacin—ABCC4—digestive system—colon cancer	0.000239	0.00405	CbGeAlD
Indomethacin—PPARG—vagina—colon cancer	0.000232	0.00394	CbGeAlD
Indomethacin—ABCC2—digestive system—colon cancer	0.000231	0.00392	CbGeAlD
Indomethacin—SLCO1B1—liver—colon cancer	0.000227	0.00385	CbGeAlD
Indomethacin—AKR1C3—lymph node—colon cancer	0.000227	0.00385	CbGeAlD
Indomethacin—ABCB1—blood vessel—colon cancer	0.000224	0.00381	CbGeAlD
Indomethacin—ABCC4—bone marrow—colon cancer	0.00022	0.00374	CbGeAlD
Indomethacin—PTGS2—embryo—colon cancer	0.000216	0.00367	CbGeAlD
Indomethacin—ABCC3—liver—colon cancer	0.000215	0.00366	CbGeAlD
Indomethacin—CES1—lymph node—colon cancer	0.000203	0.00344	CbGeAlD
Indomethacin—CYP2C19—digestive system—colon cancer	0.000198	0.00337	CbGeAlD
Indomethacin—PPARG—liver—colon cancer	0.000196	0.00332	CbGeAlD
Indomethacin—SLCO1A2—liver—colon cancer	0.000185	0.00314	CbGeAlD
Indomethacin—PTGS1—epithelium—colon cancer	0.000185	0.00314	CbGeAlD
Indomethacin—ALB—liver—colon cancer	0.000184	0.00312	CbGeAlD
Indomethacin—ABCC1—vagina—colon cancer	0.00018	0.00305	CbGeAlD
Indomethacin—PTGS1—smooth muscle tissue—colon cancer	0.000178	0.00302	CbGeAlD
Indomethacin—ABCC4—liver—colon cancer	0.000178	0.00302	CbGeAlD
Indomethacin—Skin exfoliation—Methotrexate—colon cancer	0.000177	0.00249	CcSEcCtD
Indomethacin—PTGS2—epithelium—colon cancer	0.000176	0.003	CbGeAlD
Indomethacin—CYP2C19—vagina—colon cancer	0.000175	0.00298	CbGeAlD
Indomethacin—Aplastic anaemia—Methotrexate—colon cancer	0.000174	0.00244	CcSEcCtD
Indomethacin—Flushing—Irinotecan—colon cancer	0.000173	0.00244	CcSEcCtD
Indomethacin—ABCC2—liver—colon cancer	0.000172	0.00292	CbGeAlD
Indomethacin—PTGS1—renal system—colon cancer	0.000171	0.00291	CbGeAlD
Indomethacin—PTGS2—smooth muscle tissue—colon cancer	0.00017	0.00289	CbGeAlD
Indomethacin—Alopecia—Vincristine—colon cancer	0.000169	0.00238	CcSEcCtD
Indomethacin—Coma—Methotrexate—colon cancer	0.000169	0.00238	CcSEcCtD
Indomethacin—Ecchymosis—Methotrexate—colon cancer	0.000167	0.00235	CcSEcCtD
Indomethacin—Mouth ulceration—Methotrexate—colon cancer	0.000167	0.00235	CcSEcCtD
Indomethacin—Arrhythmia—Irinotecan—colon cancer	0.000167	0.00234	CcSEcCtD
Indomethacin—Gynaecomastia—Methotrexate—colon cancer	0.000166	0.00233	CcSEcCtD
Indomethacin—ABCC3—lymph node—colon cancer	0.000165	0.0028	CbGeAlD
Indomethacin—Alopecia—Irinotecan—colon cancer	0.000165	0.00232	CcSEcCtD
Indomethacin—Abdominal pain upper—Capecitabine—colon cancer	0.000165	0.00232	CcSEcCtD
Indomethacin—Pulmonary oedema—Methotrexate—colon cancer	0.000165	0.00232	CcSEcCtD
Indomethacin—PTGS2—renal system—colon cancer	0.000164	0.00278	CbGeAlD
Indomethacin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000163	0.00229	CcSEcCtD
Indomethacin—Flatulence—Irinotecan—colon cancer	0.00016	0.00225	CcSEcCtD
Indomethacin—Gastritis—Capecitabine—colon cancer	0.00016	0.00225	CcSEcCtD
Indomethacin—Arrhythmia—Fluorouracil—colon cancer	0.00016	0.00225	CcSEcCtD
Indomethacin—Muscular weakness—Capecitabine—colon cancer	0.000159	0.00224	CcSEcCtD
Indomethacin—Alopecia—Fluorouracil—colon cancer	0.000158	0.00222	CcSEcCtD
Indomethacin—Abdominal distension—Capecitabine—colon cancer	0.000157	0.00221	CcSEcCtD
Indomethacin—Asthma—Capecitabine—colon cancer	0.000156	0.00219	CcSEcCtD
Indomethacin—Erythema—Fluorouracil—colon cancer	0.000156	0.00219	CcSEcCtD
Indomethacin—Thrombophlebitis—Methotrexate—colon cancer	0.000155	0.00218	CcSEcCtD
Indomethacin—Anaemia—Vincristine—colon cancer	0.000154	0.00217	CcSEcCtD
Indomethacin—CYP2C9—digestive system—colon cancer	0.000154	0.00261	CbGeAlD
Indomethacin—ABCC1—liver—colon cancer	0.000152	0.00257	CbGeAlD
Indomethacin—Ill-defined disorder—Irinotecan—colon cancer	0.000151	0.00212	CcSEcCtD
Indomethacin—Anaemia—Irinotecan—colon cancer	0.00015	0.00211	CcSEcCtD
Indomethacin—PPARG—lymph node—colon cancer	0.00015	0.00255	CbGeAlD
Indomethacin—Vertigo—Vincristine—colon cancer	0.00015	0.00211	CcSEcCtD
Indomethacin—Abdominal discomfort—Capecitabine—colon cancer	0.00015	0.0021	CcSEcCtD
Indomethacin—Leukopenia—Vincristine—colon cancer	0.000149	0.0021	CcSEcCtD
Indomethacin—Pancytopenia—Capecitabine—colon cancer	0.000148	0.00208	CcSEcCtD
Indomethacin—CYP2C19—liver—colon cancer	0.000148	0.00251	CbGeAlD
Indomethacin—Vision blurred—Fluorouracil—colon cancer	0.000147	0.00206	CcSEcCtD
Indomethacin—Malaise—Irinotecan—colon cancer	0.000146	0.00206	CcSEcCtD
Indomethacin—Vertigo—Irinotecan—colon cancer	0.000146	0.00205	CcSEcCtD
Indomethacin—Syncope—Irinotecan—colon cancer	0.000146	0.00205	CcSEcCtD
Indomethacin—Leukopenia—Irinotecan—colon cancer	0.000145	0.00204	CcSEcCtD
Indomethacin—Convulsion—Vincristine—colon cancer	0.000145	0.00203	CcSEcCtD
Indomethacin—Hypertension—Vincristine—colon cancer	0.000144	0.00203	CcSEcCtD
Indomethacin—Anaemia—Fluorouracil—colon cancer	0.000144	0.00202	CcSEcCtD
Indomethacin—Loss of consciousness—Irinotecan—colon cancer	0.000143	0.00201	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Methotrexate—colon cancer	0.000142	0.002	CcSEcCtD
Indomethacin—Weight increased—Capecitabine—colon cancer	0.000142	0.002	CcSEcCtD
Indomethacin—ALB—lymph node—colon cancer	0.000141	0.00239	CbGeAlD
Indomethacin—Hyperglycaemia—Capecitabine—colon cancer	0.000141	0.00198	CcSEcCtD
Indomethacin—PTGS1—digestive system—colon cancer	0.00014	0.00239	CbGeAlD
Indomethacin—Hypertension—Irinotecan—colon cancer	0.00014	0.00197	CcSEcCtD
Indomethacin—Leukopenia—Fluorouracil—colon cancer	0.000139	0.00196	CcSEcCtD
Indomethacin—Depression—Capecitabine—colon cancer	0.000139	0.00195	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000138	0.00194	CcSEcCtD
Indomethacin—Renal failure—Capecitabine—colon cancer	0.000137	0.00192	CcSEcCtD
Indomethacin—Discomfort—Irinotecan—colon cancer	0.000137	0.00192	CcSEcCtD
Indomethacin—Neuropathy peripheral—Capecitabine—colon cancer	0.000136	0.00192	CcSEcCtD
Indomethacin—ABCC4—lymph node—colon cancer	0.000136	0.00231	CbGeAlD
Indomethacin—Anaphylactic shock—Vincristine—colon cancer	0.000136	0.00191	CcSEcCtD
Indomethacin—Oedema—Vincristine—colon cancer	0.000136	0.00191	CcSEcCtD
Indomethacin—PTGS2—lymphoid tissue—colon cancer	0.000136	0.00231	CbGeAlD
Indomethacin—Stomatitis—Capecitabine—colon cancer	0.000136	0.00191	CcSEcCtD
Indomethacin—Jaundice—Capecitabine—colon cancer	0.000136	0.00191	CcSEcCtD
Indomethacin—Convulsion—Fluorouracil—colon cancer	0.000135	0.0019	CcSEcCtD
Indomethacin—Osteoarthritis—Methotrexate—colon cancer	0.000134	0.00189	CcSEcCtD
Indomethacin—PTGS2—digestive system—colon cancer	0.000134	0.00228	CbGeAlD
Indomethacin—ABCB1—embryo—colon cancer	0.000134	0.00227	CbGeAlD
Indomethacin—Confusional state—Irinotecan—colon cancer	0.000134	0.00188	CcSEcCtD
Indomethacin—Thrombocytopenia—Vincristine—colon cancer	0.000133	0.00187	CcSEcCtD
Indomethacin—Haematuria—Capecitabine—colon cancer	0.000133	0.00187	CcSEcCtD
Indomethacin—Oedema—Irinotecan—colon cancer	0.000133	0.00186	CcSEcCtD
Indomethacin—Anaphylactic shock—Irinotecan—colon cancer	0.000133	0.00186	CcSEcCtD
Indomethacin—Chest pain—Fluorouracil—colon cancer	0.000132	0.00186	CcSEcCtD
Indomethacin—ABCC2—lymph node—colon cancer	0.000132	0.00224	CbGeAlD
Indomethacin—Hyperhidrosis—Vincristine—colon cancer	0.000132	0.00185	CcSEcCtD
Indomethacin—Epistaxis—Capecitabine—colon cancer	0.000131	0.00185	CcSEcCtD
Indomethacin—Discomfort—Fluorouracil—colon cancer	0.000131	0.00184	CcSEcCtD
Indomethacin—Shock—Irinotecan—colon cancer	0.00013	0.00183	CcSEcCtD
Indomethacin—Agranulocytosis—Capecitabine—colon cancer	0.00013	0.00183	CcSEcCtD
Indomethacin—Thrombocytopenia—Irinotecan—colon cancer	0.00013	0.00183	CcSEcCtD
Indomethacin—Anorexia—Vincristine—colon cancer	0.00013	0.00182	CcSEcCtD
Indomethacin—Hyperhidrosis—Irinotecan—colon cancer	0.000128	0.0018	CcSEcCtD
Indomethacin—Confusional state—Fluorouracil—colon cancer	0.000128	0.0018	CcSEcCtD
Indomethacin—Hypotension—Vincristine—colon cancer	0.000127	0.00179	CcSEcCtD
Indomethacin—Bradycardia—Capecitabine—colon cancer	0.000127	0.00179	CcSEcCtD
Indomethacin—Oedema—Fluorouracil—colon cancer	0.000127	0.00179	CcSEcCtD
Indomethacin—Anaphylactic shock—Fluorouracil—colon cancer	0.000127	0.00179	CcSEcCtD
Indomethacin—Anorexia—Irinotecan—colon cancer	0.000126	0.00178	CcSEcCtD
Indomethacin—Haemoglobin—Capecitabine—colon cancer	0.000126	0.00177	CcSEcCtD
Indomethacin—Hepatitis—Capecitabine—colon cancer	0.000125	0.00176	CcSEcCtD
Indomethacin—Haemorrhage—Capecitabine—colon cancer	0.000125	0.00176	CcSEcCtD
Indomethacin—Thrombocytopenia—Fluorouracil—colon cancer	0.000124	0.00175	CcSEcCtD
Indomethacin—PTGS1—vagina—colon cancer	0.000124	0.00211	CbGeAlD
Indomethacin—Tachycardia—Fluorouracil—colon cancer	0.000124	0.00174	CcSEcCtD
Indomethacin—Hypotension—Irinotecan—colon cancer	0.000124	0.00174	CcSEcCtD
Indomethacin—PTGS2—bone marrow—colon cancer	0.000124	0.0021	CbGeAlD
Indomethacin—Insomnia—Vincristine—colon cancer	0.000123	0.00173	CcSEcCtD
Indomethacin—Paraesthesia—Vincristine—colon cancer	0.000122	0.00172	CcSEcCtD
Indomethacin—Anorexia—Fluorouracil—colon cancer	0.000121	0.0017	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000121	0.0017	CcSEcCtD
Indomethacin—Insomnia—Irinotecan—colon cancer	0.00012	0.00169	CcSEcCtD
Indomethacin—Paraesthesia—Irinotecan—colon cancer	0.000119	0.00167	CcSEcCtD
Indomethacin—Hypotension—Fluorouracil—colon cancer	0.000119	0.00167	CcSEcCtD
Indomethacin—PTGS2—vagina—colon cancer	0.000119	0.00201	CbGeAlD
Indomethacin—Decreased appetite—Vincristine—colon cancer	0.000118	0.00166	CcSEcCtD
Indomethacin—Dyspnoea—Irinotecan—colon cancer	0.000118	0.00166	CcSEcCtD
Indomethacin—Erythema multiforme—Capecitabine—colon cancer	0.000118	0.00166	CcSEcCtD
Indomethacin—Somnolence—Irinotecan—colon cancer	0.000118	0.00166	CcSEcCtD
Indomethacin—Fatigue—Vincristine—colon cancer	0.000117	0.00165	CcSEcCtD
Indomethacin—Dyspepsia—Irinotecan—colon cancer	0.000117	0.00164	CcSEcCtD
Indomethacin—Tinnitus—Capecitabine—colon cancer	0.000116	0.00164	CcSEcCtD
Indomethacin—Pain—Vincristine—colon cancer	0.000116	0.00164	CcSEcCtD
Indomethacin—Constipation—Vincristine—colon cancer	0.000116	0.00164	CcSEcCtD
Indomethacin—ABCC1—lymph node—colon cancer	0.000116	0.00197	CbGeAlD
Indomethacin—Asthma—Methotrexate—colon cancer	0.000116	0.00163	CcSEcCtD
Indomethacin—Flushing—Capecitabine—colon cancer	0.000116	0.00163	CcSEcCtD
Indomethacin—Decreased appetite—Irinotecan—colon cancer	0.000115	0.00162	CcSEcCtD
Indomethacin—Insomnia—Fluorouracil—colon cancer	0.000115	0.00162	CcSEcCtD
Indomethacin—CYP2C9—liver—colon cancer	0.000115	0.00195	CbGeAlD
Indomethacin—Fatigue—Irinotecan—colon cancer	0.000114	0.00161	CcSEcCtD
Indomethacin—Paraesthesia—Fluorouracil—colon cancer	0.000114	0.0016	CcSEcCtD
Indomethacin—Pain—Irinotecan—colon cancer	0.000113	0.00159	CcSEcCtD
Indomethacin—Constipation—Irinotecan—colon cancer	0.000113	0.00159	CcSEcCtD
Indomethacin—Dyspnoea—Fluorouracil—colon cancer	0.000113	0.00159	CcSEcCtD
Indomethacin—Somnolence—Fluorouracil—colon cancer	0.000113	0.00159	CcSEcCtD
Indomethacin—Dyspepsia—Fluorouracil—colon cancer	0.000112	0.00157	CcSEcCtD
Indomethacin—Arrhythmia—Capecitabine—colon cancer	0.000112	0.00157	CcSEcCtD
Indomethacin—Abdominal discomfort—Methotrexate—colon cancer	0.000111	0.00157	CcSEcCtD
Indomethacin—Gastrointestinal pain—Vincristine—colon cancer	0.000111	0.00157	CcSEcCtD
Indomethacin—Decreased appetite—Fluorouracil—colon cancer	0.00011	0.00155	CcSEcCtD
Indomethacin—Alopecia—Capecitabine—colon cancer	0.00011	0.00155	CcSEcCtD
Indomethacin—Pancytopenia—Methotrexate—colon cancer	0.00011	0.00155	CcSEcCtD
Indomethacin—Feeling abnormal—Irinotecan—colon cancer	0.000109	0.00154	CcSEcCtD
Indomethacin—ABCB1—epithelium—colon cancer	0.000109	0.00185	CbGeAlD
Indomethacin—Erythema—Capecitabine—colon cancer	0.000109	0.00153	CcSEcCtD
Indomethacin—Pain—Fluorouracil—colon cancer	0.000109	0.00153	CcSEcCtD
Indomethacin—Gastrointestinal pain—Irinotecan—colon cancer	0.000108	0.00152	CcSEcCtD
Indomethacin—Body temperature increased—Vincristine—colon cancer	0.000108	0.00151	CcSEcCtD
Indomethacin—Abdominal pain—Vincristine—colon cancer	0.000108	0.00151	CcSEcCtD
Indomethacin—Flatulence—Capecitabine—colon cancer	0.000107	0.00151	CcSEcCtD
Indomethacin—Body temperature increased—Irinotecan—colon cancer	0.000105	0.00147	CcSEcCtD
Indomethacin—Abdominal pain—Irinotecan—colon cancer	0.000105	0.00147	CcSEcCtD
Indomethacin—Feeling abnormal—Fluorouracil—colon cancer	0.000105	0.00147	CcSEcCtD
Indomethacin—Drowsiness—Methotrexate—colon cancer	0.000104	0.00146	CcSEcCtD
Indomethacin—Depression—Methotrexate—colon cancer	0.000103	0.00145	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000103	0.00144	CcSEcCtD
Indomethacin—Vision blurred—Capecitabine—colon cancer	0.000102	0.00144	CcSEcCtD
Indomethacin—Renal failure—Methotrexate—colon cancer	0.000102	0.00143	CcSEcCtD
Indomethacin—ABCB1—renal system—colon cancer	0.000101	0.00172	CbGeAlD
Indomethacin—Stomatitis—Methotrexate—colon cancer	0.000101	0.00142	CcSEcCtD
Indomethacin—Ill-defined disorder—Capecitabine—colon cancer	0.000101	0.00142	CcSEcCtD
Indomethacin—Urticaria—Fluorouracil—colon cancer	0.000101	0.00142	CcSEcCtD
Indomethacin—Anaemia—Capecitabine—colon cancer	0.0001	0.00141	CcSEcCtD
Indomethacin—Body temperature increased—Fluorouracil—colon cancer	0.0001	0.00141	CcSEcCtD
Indomethacin—Hypersensitivity—Vincristine—colon cancer	0.0001	0.00141	CcSEcCtD
Indomethacin—PTGS2—liver—colon cancer	0.0001	0.0017	CbGeAlD
Indomethacin—Sweating—Methotrexate—colon cancer	9.93e-05	0.0014	CcSEcCtD
Indomethacin—Haematuria—Methotrexate—colon cancer	9.87e-05	0.00139	CcSEcCtD
Indomethacin—Malaise—Capecitabine—colon cancer	9.8e-05	0.00138	CcSEcCtD
Indomethacin—Epistaxis—Methotrexate—colon cancer	9.77e-05	0.00137	CcSEcCtD
Indomethacin—Vertigo—Capecitabine—colon cancer	9.77e-05	0.00137	CcSEcCtD
Indomethacin—Hypersensitivity—Irinotecan—colon cancer	9.77e-05	0.00137	CcSEcCtD
Indomethacin—Asthenia—Vincristine—colon cancer	9.77e-05	0.00137	CcSEcCtD
Indomethacin—Syncope—Capecitabine—colon cancer	9.75e-05	0.00137	CcSEcCtD
Indomethacin—Leukopenia—Capecitabine—colon cancer	9.73e-05	0.00137	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—colon cancer	9.66e-05	0.00136	CcSEcCtD
Indomethacin—Palpitations—Capecitabine—colon cancer	9.61e-05	0.00135	CcSEcCtD
Indomethacin—Loss of consciousness—Capecitabine—colon cancer	9.55e-05	0.00134	CcSEcCtD
Indomethacin—Asthenia—Irinotecan—colon cancer	9.51e-05	0.00134	CcSEcCtD
Indomethacin—Hypertension—Capecitabine—colon cancer	9.39e-05	0.00132	CcSEcCtD
Indomethacin—Hypersensitivity—Fluorouracil—colon cancer	9.35e-05	0.00132	CcSEcCtD
Indomethacin—Haemoglobin—Methotrexate—colon cancer	9.34e-05	0.00131	CcSEcCtD
Indomethacin—Diarrhoea—Vincristine—colon cancer	9.31e-05	0.00131	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—colon cancer	9.3e-05	0.00131	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—colon cancer	9.3e-05	0.00131	CcSEcCtD
Indomethacin—Chest pain—Capecitabine—colon cancer	9.26e-05	0.0013	CcSEcCtD
Indomethacin—Anxiety—Capecitabine—colon cancer	9.22e-05	0.0013	CcSEcCtD
Indomethacin—Discomfort—Capecitabine—colon cancer	9.14e-05	0.00129	CcSEcCtD
Indomethacin—Diarrhoea—Irinotecan—colon cancer	9.07e-05	0.00128	CcSEcCtD
Indomethacin—Dizziness—Vincristine—colon cancer	9e-05	0.00127	CcSEcCtD
Indomethacin—Pruritus—Fluorouracil—colon cancer	8.98e-05	0.00126	CcSEcCtD
Indomethacin—Confusional state—Capecitabine—colon cancer	8.95e-05	0.00126	CcSEcCtD
Indomethacin—Oedema—Capecitabine—colon cancer	8.87e-05	0.00125	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—colon cancer	8.79e-05	0.00124	CcSEcCtD
Indomethacin—Dizziness—Irinotecan—colon cancer	8.77e-05	0.00123	CcSEcCtD
Indomethacin—Shock—Capecitabine—colon cancer	8.73e-05	0.00123	CcSEcCtD
Indomethacin—Diarrhoea—Fluorouracil—colon cancer	8.69e-05	0.00122	CcSEcCtD
Indomethacin—Thrombocytopenia—Capecitabine—colon cancer	8.69e-05	0.00122	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—colon cancer	8.67e-05	0.00122	CcSEcCtD
Indomethacin—Tachycardia—Capecitabine—colon cancer	8.66e-05	0.00122	CcSEcCtD
Indomethacin—Vomiting—Vincristine—colon cancer	8.65e-05	0.00122	CcSEcCtD
Indomethacin—Rash—Vincristine—colon cancer	8.58e-05	0.00121	CcSEcCtD
Indomethacin—Hyperhidrosis—Capecitabine—colon cancer	8.58e-05	0.00121	CcSEcCtD
Indomethacin—Dermatitis—Vincristine—colon cancer	8.57e-05	0.00121	CcSEcCtD
Indomethacin—Headache—Vincristine—colon cancer	8.53e-05	0.0012	CcSEcCtD
Indomethacin—Anorexia—Capecitabine—colon cancer	8.46e-05	0.00119	CcSEcCtD
Indomethacin—Vomiting—Irinotecan—colon cancer	8.43e-05	0.00119	CcSEcCtD
Indomethacin—ABCB1—lymphoid tissue—colon cancer	8.41e-05	0.00143	CbGeAlD
Indomethacin—Dizziness—Fluorouracil—colon cancer	8.4e-05	0.00118	CcSEcCtD
Indomethacin—Rash—Irinotecan—colon cancer	8.36e-05	0.00118	CcSEcCtD
Indomethacin—Dermatitis—Irinotecan—colon cancer	8.35e-05	0.00117	CcSEcCtD
Indomethacin—ABCB1—digestive system—colon cancer	8.3e-05	0.00141	CbGeAlD
Indomethacin—Headache—Irinotecan—colon cancer	8.3e-05	0.00117	CcSEcCtD
Indomethacin—Hypotension—Capecitabine—colon cancer	8.29e-05	0.00117	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—colon cancer	8.21e-05	0.00116	CcSEcCtD
Indomethacin—Erythema—Methotrexate—colon cancer	8.09e-05	0.00114	CcSEcCtD
Indomethacin—Nausea—Vincristine—colon cancer	8.09e-05	0.00114	CcSEcCtD
Indomethacin—Vomiting—Fluorouracil—colon cancer	8.07e-05	0.00114	CcSEcCtD
Indomethacin—Insomnia—Capecitabine—colon cancer	8.02e-05	0.00113	CcSEcCtD
Indomethacin—PTGS1—lymph node—colon cancer	8.02e-05	0.00136	CbGeAlD
Indomethacin—Rash—Fluorouracil—colon cancer	8.01e-05	0.00113	CcSEcCtD
Indomethacin—Dermatitis—Fluorouracil—colon cancer	8e-05	0.00112	CcSEcCtD
Indomethacin—Paraesthesia—Capecitabine—colon cancer	7.97e-05	0.00112	CcSEcCtD
Indomethacin—Headache—Fluorouracil—colon cancer	7.95e-05	0.00112	CcSEcCtD
Indomethacin—Dyspnoea—Capecitabine—colon cancer	7.91e-05	0.00111	CcSEcCtD
Indomethacin—Nausea—Irinotecan—colon cancer	7.87e-05	0.00111	CcSEcCtD
Indomethacin—Dyspepsia—Capecitabine—colon cancer	7.81e-05	0.0011	CcSEcCtD
Indomethacin—Decreased appetite—Capecitabine—colon cancer	7.71e-05	0.00108	CcSEcCtD
Indomethacin—PTGS2—lymph node—colon cancer	7.67e-05	0.0013	CbGeAlD
Indomethacin—ABCB1—bone marrow—colon cancer	7.66e-05	0.0013	CbGeAlD
Indomethacin—Fatigue—Capecitabine—colon cancer	7.65e-05	0.00108	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—colon cancer	7.63e-05	0.00107	CcSEcCtD
Indomethacin—Constipation—Capecitabine—colon cancer	7.59e-05	0.00107	CcSEcCtD
Indomethacin—Pain—Capecitabine—colon cancer	7.59e-05	0.00107	CcSEcCtD
Indomethacin—Nausea—Fluorouracil—colon cancer	7.54e-05	0.00106	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—colon cancer	7.51e-05	0.00106	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—colon cancer	7.48e-05	0.00105	CcSEcCtD
Indomethacin—ABCB1—vagina—colon cancer	7.33e-05	0.00125	CbGeAlD
Indomethacin—Feeling abnormal—Capecitabine—colon cancer	7.31e-05	0.00103	CcSEcCtD
Indomethacin—Malaise—Methotrexate—colon cancer	7.3e-05	0.00103	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—colon cancer	7.27e-05	0.00102	CcSEcCtD
Indomethacin—Gastrointestinal pain—Capecitabine—colon cancer	7.25e-05	0.00102	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—colon cancer	7.24e-05	0.00102	CcSEcCtD
Indomethacin—Urticaria—Capecitabine—colon cancer	7.05e-05	0.000991	CcSEcCtD
Indomethacin—Abdominal pain—Capecitabine—colon cancer	7.01e-05	0.000986	CcSEcCtD
Indomethacin—Body temperature increased—Capecitabine—colon cancer	7.01e-05	0.000986	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—colon cancer	7.01e-05	0.000986	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—colon cancer	6.89e-05	0.000969	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—colon cancer	6.81e-05	0.000957	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—colon cancer	6.66e-05	0.000937	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—colon cancer	6.6e-05	0.000929	CcSEcCtD
Indomethacin—Hypersensitivity—Capecitabine—colon cancer	6.54e-05	0.000919	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—colon cancer	6.47e-05	0.00091	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—colon cancer	6.38e-05	0.000898	CcSEcCtD
Indomethacin—Asthenia—Capecitabine—colon cancer	6.37e-05	0.000895	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—colon cancer	6.3e-05	0.000885	CcSEcCtD
Indomethacin—Pruritus—Capecitabine—colon cancer	6.28e-05	0.000883	CcSEcCtD
Indomethacin—ABCB1—liver—colon cancer	6.19e-05	0.00105	CbGeAlD
Indomethacin—Hypotension—Methotrexate—colon cancer	6.17e-05	0.000868	CcSEcCtD
Indomethacin—Diarrhoea—Capecitabine—colon cancer	6.07e-05	0.000854	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—colon cancer	5.97e-05	0.00084	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—colon cancer	5.93e-05	0.000834	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—colon cancer	5.89e-05	0.000828	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—colon cancer	5.87e-05	0.000826	CcSEcCtD
Indomethacin—Dizziness—Capecitabine—colon cancer	5.87e-05	0.000825	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—colon cancer	5.81e-05	0.000818	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—colon cancer	5.74e-05	0.000808	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—colon cancer	5.69e-05	0.000801	CcSEcCtD
Indomethacin—Pain—Methotrexate—colon cancer	5.65e-05	0.000794	CcSEcCtD
Indomethacin—Vomiting—Capecitabine—colon cancer	5.64e-05	0.000793	CcSEcCtD
Indomethacin—Rash—Capecitabine—colon cancer	5.59e-05	0.000787	CcSEcCtD
Indomethacin—Dermatitis—Capecitabine—colon cancer	5.59e-05	0.000786	CcSEcCtD
Indomethacin—Headache—Capecitabine—colon cancer	5.56e-05	0.000782	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—colon cancer	5.44e-05	0.000766	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—colon cancer	5.4e-05	0.00076	CcSEcCtD
Indomethacin—Nausea—Capecitabine—colon cancer	5.27e-05	0.000741	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—colon cancer	5.25e-05	0.000738	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—colon cancer	5.22e-05	0.000734	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—colon cancer	5.22e-05	0.000734	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—colon cancer	4.87e-05	0.000684	CcSEcCtD
Indomethacin—ABCB1—lymph node—colon cancer	4.74e-05	0.000806	CbGeAlD
Indomethacin—Asthenia—Methotrexate—colon cancer	4.74e-05	0.000667	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—colon cancer	4.67e-05	0.000657	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—colon cancer	4.52e-05	0.000636	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—colon cancer	4.37e-05	0.000614	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—colon cancer	4.2e-05	0.000591	CcSEcCtD
Indomethacin—Rash—Methotrexate—colon cancer	4.16e-05	0.000586	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—colon cancer	4.16e-05	0.000585	CcSEcCtD
Indomethacin—Headache—Methotrexate—colon cancer	4.14e-05	0.000582	CcSEcCtD
Indomethacin—Nausea—Methotrexate—colon cancer	3.92e-05	0.000552	CcSEcCtD
Indomethacin—PTGDR2—Signaling Pathways—PIK3CA—colon cancer	8.8e-06	0.00019	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	8.77e-06	0.000189	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—BRAF—colon cancer	8.75e-06	0.000188	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—TYMS—colon cancer	8.68e-06	0.000187	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—KRAS—colon cancer	8.63e-06	0.000186	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—colon cancer	8.52e-06	0.000183	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—colon cancer	8.45e-06	0.000182	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.43e-06	0.000181	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EP300—colon cancer	8.39e-06	0.000181	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.34e-06	0.000179	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.26e-06	0.000178	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ABCB1—colon cancer	8.25e-06	0.000178	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ABCB1—colon cancer	8.25e-06	0.000178	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—EP300—colon cancer	8.18e-06	0.000176	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	8.17e-06	0.000176	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—SRC—colon cancer	8.16e-06	0.000176	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—colon cancer	8.15e-06	0.000175	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.13e-06	0.000175	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—TYMS—colon cancer	8.1e-06	0.000174	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—TYMS—colon cancer	8.1e-06	0.000174	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	8.07e-06	0.000174	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	8.05e-06	0.000173	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—FGFR3—colon cancer	8e-06	0.000172	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ABCB1—colon cancer	7.95e-06	0.000171	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—PIK3CA—colon cancer	7.92e-06	0.000171	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.89e-06	0.00017	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	7.89e-06	0.00017	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NRAS—colon cancer	7.85e-06	0.000169	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—TYMS—colon cancer	7.81e-06	0.000168	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.72e-06	0.000166	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.67e-06	0.000165	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—colon cancer	7.67e-06	0.000165	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ABCB1—colon cancer	7.56e-06	0.000163	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—colon cancer	7.52e-06	0.000162	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	7.46e-06	0.000161	CbGpPWpGaD
Indomethacin—ABCC1—Disease—FGFR3—colon cancer	7.46e-06	0.00016	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—TYMS—colon cancer	7.42e-06	0.00016	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—APC—colon cancer	7.34e-06	0.000158	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NRAS—colon cancer	7.34e-06	0.000158	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—colon cancer	7.33e-06	0.000158	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—colon cancer	7.33e-06	0.000158	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MYC—colon cancer	7.32e-06	0.000157	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TGFB1—colon cancer	7.3e-06	0.000157	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.26e-06	0.000156	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AKT1—colon cancer	7.19e-06	0.000155	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EGFR—colon cancer	7.15e-06	0.000154	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PIK3CA—colon cancer	7.11e-06	0.000153	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PPARG—colon cancer	7.06e-06	0.000152	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PPARG—colon cancer	7.06e-06	0.000152	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—EP300—colon cancer	7.03e-06	0.000151	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	6.96e-06	0.00015	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—BRAF—colon cancer	6.9e-06	0.000149	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.87e-06	0.000148	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.85e-06	0.000147	CbGpPWpGaD
Indomethacin—ABCC1—Disease—APC—colon cancer	6.84e-06	0.000147	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MYC—colon cancer	6.83e-06	0.000147	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KRAS—colon cancer	6.76e-06	0.000146	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.75e-06	0.000145	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ABCB1—colon cancer	6.72e-06	0.000145	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—EGFR—colon cancer	6.69e-06	0.000144	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.68e-06	0.000144	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—colon cancer	6.64e-06	0.000143	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.63e-06	0.000143	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TYMS—colon cancer	6.6e-06	0.000142	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CASP3—colon cancer	6.56e-06	0.000141	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—colon cancer	6.47e-06	0.000139	CbGpPWpGaD
Indomethacin—ABCC1—Disease—BRAF—colon cancer	6.43e-06	0.000139	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—PIK3CA—colon cancer	6.39e-06	0.000138	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCND1—colon cancer	6.39e-06	0.000137	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CTNNB1—colon cancer	6.32e-06	0.000136	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—colon cancer	6.32e-06	0.000136	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.24e-06	0.000134	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PIK3CA—colon cancer	6.21e-06	0.000134	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CDKN1A—colon cancer	6.18e-06	0.000133	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—colon cancer	6.15e-06	0.000132	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—EP300—colon cancer	6.1e-06	0.000131	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.06e-06	0.00013	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—colon cancer	6.05e-06	0.00013	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.01e-06	0.000129	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EP300—colon cancer	5.88e-06	0.000127	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—colon cancer	5.81e-06	0.000125	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—colon cancer	5.81e-06	0.000125	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—colon cancer	5.75e-06	0.000124	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—colon cancer	5.74e-06	0.000124	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—colon cancer	5.74e-06	0.000124	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SRC—colon cancer	5.72e-06	0.000123	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.71e-06	0.000123	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	5.68e-06	0.000122	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.6e-06	0.00012	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—colon cancer	5.57e-06	0.00012	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—colon cancer	5.55e-06	0.00012	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—colon cancer	5.55e-06	0.00012	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—colon cancer	5.53e-06	0.000119	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.52e-06	0.000119	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—colon cancer	5.5e-06	0.000118	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.45e-06	0.000117	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—colon cancer	5.37e-06	0.000116	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ABCB1—colon cancer	5.34e-06	0.000115	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.31e-06	0.000114	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—colon cancer	5.26e-06	0.000113	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—colon cancer	5.25e-06	0.000113	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TYMS—colon cancer	5.24e-06	0.000113	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—colon cancer	5.22e-06	0.000112	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—colon cancer	5.2e-06	0.000112	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—colon cancer	5.2e-06	0.000112	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—colon cancer	5.18e-06	0.000111	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—colon cancer	5.12e-06	0.00011	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—colon cancer	5.11e-06	0.00011	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.08e-06	0.000109	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—colon cancer	5.07e-06	0.000109	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—colon cancer	5.04e-06	0.000108	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—colon cancer	5.01e-06	0.000108	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGFR3—colon cancer	5e-06	0.000108	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CTNNB1—colon cancer	4.99e-06	0.000107	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—colon cancer	4.94e-06	0.000106	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—colon cancer	4.9e-06	0.000105	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1A—colon cancer	4.87e-06	0.000105	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—EP300—colon cancer	4.85e-06	0.000104	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—colon cancer	4.84e-06	0.000104	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.76e-06	0.000103	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—colon cancer	4.74e-06	0.000102	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—colon cancer	4.74e-06	0.000102	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—colon cancer	4.73e-06	0.000102	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—colon cancer	4.71e-06	0.000101	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—colon cancer	4.68e-06	0.000101	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—colon cancer	4.65e-06	0.0001	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—colon cancer	4.64e-06	9.98e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—colon cancer	4.62e-06	9.94e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—colon cancer	4.62e-06	9.94e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—colon cancer	4.59e-06	9.89e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—colon cancer	4.59e-06	9.88e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—colon cancer	4.54e-06	9.78e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—colon cancer	4.53e-06	9.76e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—colon cancer	4.51e-06	9.72e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—colon cancer	4.51e-06	9.72e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—colon cancer	4.51e-06	9.71e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—colon cancer	4.51e-06	9.71e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.41e-06	9.5e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—colon cancer	4.39e-06	9.45e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—colon cancer	4.37e-06	9.4e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—colon cancer	4.35e-06	9.37e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—colon cancer	4.35e-06	9.36e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.34e-06	9.35e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—colon cancer	4.34e-06	9.34e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—colon cancer	4.32e-06	9.3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—colon cancer	4.32e-06	9.3e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—colon cancer	4.32e-06	9.29e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—colon cancer	4.25e-06	9.15e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—colon cancer	4.24e-06	9.13e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—colon cancer	4.21e-06	9.07e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—colon cancer	4.21e-06	9.06e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—colon cancer	4.2e-06	9.05e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—colon cancer	4.14e-06	8.9e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—colon cancer	4.04e-06	8.7e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—colon cancer	4.04e-06	8.7e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.04e-06	8.69e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—colon cancer	4.03e-06	8.68e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—colon cancer	4.02e-06	8.66e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—colon cancer	4.02e-06	8.66e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.96e-06	8.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—colon cancer	3.95e-06	8.51e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—colon cancer	3.9e-06	8.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—colon cancer	3.88e-06	8.34e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—colon cancer	3.81e-06	8.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—colon cancer	3.77e-06	8.11e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—colon cancer	3.76e-06	8.09e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—colon cancer	3.75e-06	8.08e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—colon cancer	3.75e-06	8.08e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—colon cancer	3.73e-06	8.04e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—colon cancer	3.72e-06	8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—colon cancer	3.71e-06	7.99e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—colon cancer	3.68e-06	7.93e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—colon cancer	3.68e-06	7.93e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—colon cancer	3.68e-06	7.92e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—colon cancer	3.62e-06	7.79e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.61e-06	7.78e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—colon cancer	3.59e-06	7.72e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—colon cancer	3.55e-06	7.65e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—colon cancer	3.53e-06	7.61e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—colon cancer	3.48e-06	7.49e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—colon cancer	3.47e-06	7.47e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—colon cancer	3.47e-06	7.47e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—colon cancer	3.44e-06	7.4e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—colon cancer	3.43e-06	7.38e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—colon cancer	3.42e-06	7.36e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—colon cancer	3.42e-06	7.36e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—colon cancer	3.39e-06	7.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—colon cancer	3.32e-06	7.14e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—colon cancer	3.32e-06	7.14e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.26e-06	7.03e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—colon cancer	3.23e-06	6.96e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—colon cancer	3.2e-06	6.88e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—colon cancer	3.17e-06	6.83e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—colon cancer	3.12e-06	6.72e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—colon cancer	3.06e-06	6.59e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—colon cancer	3.05e-06	6.56e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—colon cancer	3e-06	6.47e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—colon cancer	2.98e-06	6.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—colon cancer	2.96e-06	6.37e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.93e-06	6.31e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—colon cancer	2.93e-06	6.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—colon cancer	2.9e-06	6.24e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—colon cancer	2.82e-06	6.07e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—colon cancer	2.8e-06	6.03e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—colon cancer	2.79e-06	6.01e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—colon cancer	2.79e-06	6.01e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—colon cancer	2.78e-06	5.98e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—colon cancer	2.78e-06	5.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—colon cancer	2.71e-06	5.84e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—colon cancer	2.7e-06	5.81e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—colon cancer	2.68e-06	5.76e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.67e-06	5.75e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—colon cancer	2.64e-06	5.68e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—colon cancer	2.63e-06	5.67e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—colon cancer	2.61e-06	5.62e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—colon cancer	2.54e-06	5.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—colon cancer	2.53e-06	5.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—colon cancer	2.52e-06	5.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—colon cancer	2.47e-06	5.32e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—colon cancer	2.46e-06	5.29e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—colon cancer	2.43e-06	5.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—colon cancer	2.43e-06	5.23e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—colon cancer	2.36e-06	5.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—colon cancer	2.34e-06	5.03e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—colon cancer	2.27e-06	4.88e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—colon cancer	2.27e-06	4.88e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—colon cancer	2.26e-06	4.87e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—colon cancer	2.19e-06	4.71e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—colon cancer	2.15e-06	4.62e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—colon cancer	2.12e-06	4.57e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—colon cancer	2.08e-06	4.47e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—colon cancer	2.07e-06	4.46e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—colon cancer	1.99e-06	4.27e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—colon cancer	1.97e-06	4.23e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—colon cancer	1.93e-06	4.16e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—colon cancer	1.85e-06	3.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—colon cancer	1.8e-06	3.87e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—colon cancer	1.76e-06	3.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—colon cancer	1.75e-06	3.77e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—colon cancer	1.72e-06	3.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—colon cancer	1.61e-06	3.46e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—colon cancer	1.47e-06	3.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—colon cancer	1.45e-06	3.13e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—colon cancer	1.31e-06	2.81e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—colon cancer	1.27e-06	2.74e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—colon cancer	1.19e-06	2.56e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—colon cancer	1.19e-06	2.56e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—colon cancer	1.07e-06	2.3e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—colon cancer	1.04e-06	2.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—colon cancer	9.72e-07	2.09e-05	CbGpPWpGaD
